Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boyle

Showing results (1161-1170 of 1,217) with videos related to

Pageof 122
Sort By:
British Journal of Haematology|June 21, 2019
Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trialEileen M Boyle, Xavier Leleu, Marie-Odile Petillon, et al.
MMWR. Morbidity and Mortality Weekly Report|June 29, 2023
Preliminary Incidence and Trends of Infections Caused by Pathogens Transmitted Commonly Through Food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2022Miranda J Delahoy, Hazel J Shah, Daniel Lowell Weller, et al.
Circulation. Arrhythmia and Electrophysiology|May 20, 2025
STAR Locally Prolongs Effective Refractory Period and Increases Ventricular Tachycardia Cycle Length Without Short-Term Scar Formation or Functional Decline: Insights From a Translational Porcine Model StudyBrian Zenger, Timothy W Smith, Stephanie Hicks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 29, 2016
The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in MyelomaCharlotte Pawlyn, Martin F Kaiser, Christoph Heuck, et al.
Nature Chemical Biology|April 28, 2025
Monitoring in real time and far-red imaging of H<sub>2</sub>O<sub>2</sub> dynamics with subcellular resolutionJustin Daho Lee, Amanda Nguyen, Chelsea E Gibbs, et al.
Cancer Immunology Research|May 24, 2020
ASC Modulates CTL Cytotoxicity and Transplant Outcome Independent of the InflammasomeMelody Cheong, Kate H Gartlan, Jason S Lee, et al.
Cardio-Oncology (London, England)|October 10, 2024
Building a machine learning-assisted echocardiography prediction tool for children at risk for cancer therapy-related cardiomyopathyLindsay A Edwards, Christina Yang, Surbhi Sharma, et al.
Blood|July 25, 2015
Tc17 cells are a proinflammatory, plastic lineage of pathogenic CD8+ T cells that induce GVHD without antileukemic effectsKate H Gartlan, Kate A Markey, Antiopi Varelias, et al.
Journal for Immunotherapy of Cancer|April 24, 2024
Tigilanol tiglate is an oncolytic small molecule that induces immunogenic cell death and enhances the response of both target and non-injected tumors to immune checkpoint blockadeJason K Cullen, Pei-Yi Yap, Blake Ferguson, et al.
Blood Cancer Discovery|January 4, 2021
Revealing the impact of structural variants in multiple myelomaEven H Rustad, Venkata D Yellapantula, Dominik Glodzik, et al.
Pageof 122

Showing results (1161-1170 of 1,217) with videos related to

Sort By:
Pageof 122
British Journal of Haematology|June 21, 2019
Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trialEileen M Boyle, Xavier Leleu, Marie-Odile Petillon, et al.
MMWR. Morbidity and Mortality Weekly Report|June 29, 2023
Preliminary Incidence and Trends of Infections Caused by Pathogens Transmitted Commonly Through Food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2022Miranda J Delahoy, Hazel J Shah, Daniel Lowell Weller, et al.
Circulation. Arrhythmia and Electrophysiology|May 20, 2025
STAR Locally Prolongs Effective Refractory Period and Increases Ventricular Tachycardia Cycle Length Without Short-Term Scar Formation or Functional Decline: Insights From a Translational Porcine Model StudyBrian Zenger, Timothy W Smith, Stephanie Hicks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 29, 2016
The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in MyelomaCharlotte Pawlyn, Martin F Kaiser, Christoph Heuck, et al.
Nature Chemical Biology|April 28, 2025
Monitoring in real time and far-red imaging of H<sub>2</sub>O<sub>2</sub> dynamics with subcellular resolutionJustin Daho Lee, Amanda Nguyen, Chelsea E Gibbs, et al.
Cancer Immunology Research|May 24, 2020
ASC Modulates CTL Cytotoxicity and Transplant Outcome Independent of the InflammasomeMelody Cheong, Kate H Gartlan, Jason S Lee, et al.
Cardio-Oncology (London, England)|October 10, 2024
Building a machine learning-assisted echocardiography prediction tool for children at risk for cancer therapy-related cardiomyopathyLindsay A Edwards, Christina Yang, Surbhi Sharma, et al.
Blood|July 25, 2015
Tc17 cells are a proinflammatory, plastic lineage of pathogenic CD8+ T cells that induce GVHD without antileukemic effectsKate H Gartlan, Kate A Markey, Antiopi Varelias, et al.
Journal for Immunotherapy of Cancer|April 24, 2024
Tigilanol tiglate is an oncolytic small molecule that induces immunogenic cell death and enhances the response of both target and non-injected tumors to immune checkpoint blockadeJason K Cullen, Pei-Yi Yap, Blake Ferguson, et al.
Blood Cancer Discovery|January 4, 2021
Revealing the impact of structural variants in multiple myelomaEven H Rustad, Venkata D Yellapantula, Dominik Glodzik, et al.
Pageof 122